Jagdish Shah, MD
Psychiatry · Rock Hill, SCNPI 1356301360
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $280,918 of the $320,464 with a category attached, or 87.7%. Teva Pharmaceuticals USA, Inc. accounts for 93.9% of it on its own, with 10 other manufacturers making up the rest. Among psychiatry clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 358 payments — averaging $895.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$301K
- Alkermes, Inc.$16K
- Sunovion Pharmaceuticals Inc.$3K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$233
- Johnson & Johnson$174
- Indivior Inc.$41
- plus $106 from 5 others
What the payments were for
- Consulting fees$3,5601%
- Speaking & faculty fees$280,91888%
- Travel & lodging$30,54110%
- Food & beverage$5,3212%
- Education$1240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 290 | $300,832 |
| Alkermes, Inc. | 29 | $15,805 |
| Sunovion Pharmaceuticals Inc. | 15 | $3,274 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $233 |
| Johnson & Johnson | 12 | $174 |
| Indivior Inc. | 2 | $41 |
| Neurocrine Biosciences, Inc. | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| AbbVie | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUSTEDO$161,834
- UZEDY$76,398
- ARISTADA$61,307
- Austedo XR$57,096
- ARISTADA INITIO$15,327
- LATUDA$3,095
How this compares
$320,464 in reported general payments places this provider in the 95th percentile of 624 psychiatry providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 88 | $851,645 |
| Invega SustennaPaliperidone Palmitate | 129 | $426,107 |
| UzedyRisperidone | 95 | $410,336 |
| AustedoDeutetrabenazine | 27 | $264,191 |
| Abilify MaintenaAripiprazole | 54 | $157,036 |
| CaplytaLumateperone Tosylate | 11 | $19,319 |
| Fluphenazine Decanoate | 79 | $9,196 |
| Clozapine | 66 | $5,633 |
| Paliperidone ErPaliperidone | 34 | $4,928 |
| Venlafaxine Besylate ErVenlafaxine Besylate | 12 | $4,694 |
| Lurasidone Hcl | 67 | $3,528 |
| Quetiapine Fumarate | 105 | $3,266 |
| Benztropine Mesylate | 179 | $2,476 |
| Olanzapine | 124 | $2,273 |
| Divalproex Sodium ErDivalproex Sodium | 82 | $2,117 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr, Uzedy, Austedo | $300,832 | $1,526,172210 claims |
| Johnson & JohnsonInvega Sustenna | $174 | $426,107129 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $14 | $157,03654 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $233 | $19,31911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 624 psychiatry providers in South Carolina.
Other psychiatry in Rock Hill
- Tammy ChenRock Hill$6K
- Brittany AlbrightMount Pleasant$691K
- Veronica RidpathFlorence$364K
- Ricardo FermoCharleston$262K
- John DewittAiken$221K
- Jeffrey StephensGreenville$195K
- Robert RichardsGreenville$142K
- Nikunjkumar ModiFlorence$133K
- Jacobo MintzerCharleston$132K
- Murray HonickMyrtle Beach$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.